Inviting your body to heal from within.
At a glance
What it is
Prolotherapy is a complementary injection therapy that uses dextrose-based solutions to potentially stimulate the body's tissue repair response in areas of chronic musculoskeletal pain or joint instability.
Why people explore it
How it’s experienced
A typical prolotherapy session begins with a detailed consultation in which the practitioner reviews the patient's history, prior imaging or diagnostic results, and specific areas of concern.
Evidence context
Emerging evidenceSee the evidence snapshotSafety
Typical risk: Moderate
See staying safeHistory & Origin
Prolotherapy — short for proliferative therapy — is a minimally invasive injection-based treatment used by some practitioners to address chronic musculoskeletal pain, joint instability, and connective tissue concerns. The approach involves injecting a solution, most commonly a dextrose (sugar water) mixture, into areas of perceived structural weakness such as tendons, ligaments, and joint spaces. The goal, as understood by practitioners, is to stimulate the body's own healing response in tissues that may have become chronically painful due to incomplete recovery from injury or overuse.
Prolotherapy sits within the broader landscape of regenerative and injection-based therapies, which also includes platelet-rich plasma (PRP) and stem cell treatments. Unlike corticosteroid injections, which are primarily aimed at reducing inflammation, prolotherapy is theorized to work by initiating a localized, controlled inflammatory response that may encourage tissue repair. Some practitioners view it as a way to address the root structural cause of pain rather than simply managing symptoms.
The practice attracts individuals who feel they have not found adequate relief through conventional treatments such as physical therapy, anti-inflammatory medications, or surgery. It is often sought for conditions involving ligament laxity, tendon degeneration, or persistent joint discomfort. Prolotherapy is typically administered by physicians, osteopathic doctors, or other licensed medical professionals with specialized training. While interest in the modality has grown in integrative and sports medicine circles, it remains categorized as a complementary approach, and prospective patients are encouraged to discuss it carefully with a qualified healthcare provider before proceeding.
The roots of prolotherapy can be traced back to the early twentieth century, when physicians began experimenting with injection-based techniques to address joint pain and instability. The term 'prolotherapy' itself is generally attributed to George Stuart Hackett, an American physician who developed and documented injection protocols for ligament and tendon repair during the 1950s. Hackett's work laid an early foundation for the modern practice, and he is often credited with coining the 'prolo' prefix, derived from 'proliferant,' referencing the stimulation of new tissue growth.
The approach evolved further through the contributions of subsequent practitioners in osteopathic and integrative medicine, who refined injection techniques and explored expanded applications. By the late twentieth century, prolotherapy had gained a niche following in sports medicine, pain management, and complementary health circles across North America and parts of Europe.
Historically, the practice has occupied a complicated position — enthusiastically adopted by some clinicians and their patients, yet regarded with skepticism by conventional medical institutions due to limited large-scale research. That dynamic continues today, though growing interest in regenerative medicine has brought renewed attention and research investment to injection-based therapies, of which prolotherapy is considered an earlier predecessor.
Mechanism
Prolotherapy is thought to work by prompting the body's own repair mechanisms in areas of chronic connective tissue weakness.
The evidence
An honest read on how Prolotherapy has been studied — an evidence tier and the research behind it, not a guarantee and not a ranking of “better.”
An emerging area of research
The evidence base for prolotherapy is best described as emerging.
See History & origin above for the full account.
Moderate risk — See Staying safe below for full guidance.
5 peer-reviewed studies referenced, spanning 2018–2024 — see References below.
Safety first
General, informational guidance — not diagnostic. A qualified practitioner can advise on your own situation.
For you?
A simple, human way to weigh it up. This is general guidance, not personal medical advice — a qualified practitioner can advise on your situation.
Gyfts is a discovery platform, not a medical provider. Nothing here diagnoses, treats or replaces professional care. In an emergency, contact your local emergency number.
Featured
Verified practitioners whose work commonly involves this practice. Featured placement does not affect organic ranking or recommendations.
Read next
FAQ
The number of sessions varies depending on the individual, the area being treated, and the practitioner's protocol. Most courses involve between three and six sessions spaced several weeks apart, though some individuals may need more or fewer visits. A qualified practitioner can offer a more personalized estimate after an initial evaluation.
Prolotherapy, PRP (platelet-rich plasma), and stem cell injections are distinct therapies that fall under the broader umbrella of regenerative injection treatments. Prolotherapy most commonly uses a dextrose-based solution, while PRP uses components derived from the patient's own blood. Each has its own proposed mechanism, evidence profile, and clinical applications.
In many regions, prolotherapy is not consistently covered by standard health insurance plans, as it is still considered an emerging or experimental therapy by many payers. Coverage can vary significantly depending on the insurer, the condition being treated, and the geographic location. It is advisable to check directly with your insurance provider before scheduling treatment.
Sources
Educational sources that inform this overview. Inclusion is for context and does not imply endorsement.
Full citations are maintained by the Gyfts editorial team and reviewed periodically.
Keep exploring
Browse verified practitioners, explore honest overviews, and take what you learn to a conversation — at your own pace.
